Walter's Pharmacy Recalls Lidocaine Nebulizer Solution Due to Sterility Concerns
Walter's Pharmacy is recalling Lidocaine Nebulizer 2% Solution because the product lacks assurance of sterility. The recall affects 5 bottles distributed in Pennsylvania.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls with potential for adverse health consequences are rated as Severe (4), particularly when the hazard involves sterility assurance for a medical product.
Plain-English summary
Walter's Pharmacy is recalling Lidocaine Nebulizer 2% Solution, packaged in 50mL, 100mL, 120mL, and 150mL bottles. The recall is due to a lack of assurance of sterility. The product is prescription-only and carries NDC 99999-9000-99.
The recall involves 5 bottles with lot numbers 010516 and 012016. These products were distributed in Pennsylvania. Walter's Pharmacy is located at 401 N 17th St, Allentown, PA.
Consumers who have this product should contact their healthcare provider or Walter's Pharmacy for instructions on how to proceed. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Lidocaine Nebulizer 2% Solution, packaged in 50mL, 100mL, 120mL, and 150mL bottles, Rx only, Walter's Pharmacy, 401 N 17th St, Allentown, PA 610-435-4706, NDC 99999-9000-99
- Manufacturer
- Walter's Pharmacy
- Category
- Drug — Nebulizer Solution
- Hazard
- Affected units
- 5
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 010516
- 012016
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 13 recalled by Walter's Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · Walter's Pharmacy
See all →- SevereWalter's Pharmacy Recalls Silver Nitrate Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
- SevereWalter's Pharmacy Recalls Tobramycin Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
- SevereWalter's Pharmacy Recalls Acetylcysteine Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
- SevereWalter's Pharmacy Recalls Cefazolin Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
- SevereWalter's Pharmacy Recalls Edetate Disodium Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
Same hazard · sterility
See all →- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Ultra Lubricating Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- HighMartin Avenue Pharmacy Recalls Lidocaine 2% Injectable Due to Sterility Concerns
FDA (Drugs) · 2014-11-05
- HighLidocaine Injectable Solution Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2023-05-31
- SevereWestern Drug Recalls Lidocaine Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereNora Apothecary Recalls Lidocaine 2% Injection Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
- SeverePharmakon Recalls Lidocaine Syringes Due to Sterility Assurance Concerns
FDA (Drugs) · 2016-07-20
- HighMartin Avenue Pharmacy Recalls Lidocaine 1% Injectable Vials
FDA (Drugs) · 2014-11-05